Nektar Therapeutics Other Current Assets (Quarterly) Insights

Nektar Therapeutics (NKTR)

37.68 +2.32 (+6.56%) USD | NASDAQ | Jan 16, 16:00

37.20 -0.48 (-1.27%) After-Hours: 07:58

View Other Current Assets (Quarterly) for NKTR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Assets (Quarterly) Benchmarks

Start Trial

Rigel Pharmaceuticals, Inc.	Upgrade
Insmed, Inc.	Upgrade
Eli Lilly & Co.	Upgrade
Ironwood Pharmaceuticals, Inc.	Upgrade
Lyell Immunopharma, Inc.	Upgrade